1-(1-(5-Aminopyridin-2-yl)piperidin-2-yl)ethan-1-ol
95%
- Product Code: 123748
CAS:
2098118-21-7
Molecular Weight: | 221.3 g./mol | Molecular Formula: | C₁₂H₁₉N₃O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various therapeutic agents. Its structure, featuring both a piperidine ring and an aminopyridine moiety, makes it a valuable building block for developing drugs targeting the central nervous system. It is particularly relevant in the design of compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, its functional groups allow for further chemical modifications, enabling the creation of derivatives with enhanced biological activity or improved pharmacokinetic profiles. Research efforts often focus on its role in developing selective receptor modulators, contributing to advancements in treating neurological and psychiatric disorders.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿17,118.00 |
+
-
|
0.250 | 10-20 days | ฿34,236.00 |
+
-
|
1-(1-(5-Aminopyridin-2-yl)piperidin-2-yl)ethan-1-ol
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various therapeutic agents. Its structure, featuring both a piperidine ring and an aminopyridine moiety, makes it a valuable building block for developing drugs targeting the central nervous system. It is particularly relevant in the design of compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, its functional groups allow for further chemical modifications, enabling the creation of derivatives with enhanced biological activity or improved pharmacokinetic profiles. Research efforts often focus on its role in developing selective receptor modulators, contributing to advancements in treating neurological and psychiatric disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :